CA Patent

CA2836449C — Kinase inhibitors

Assigned to Principia Biopharma Inc · Expires 2021-04-27 · 5y expired

What this patent protects

Provided herein are kinase inhibiting compounds and methods of using the same.

USPTO Abstract

Provided herein are kinase inhibiting compounds and methods of using the same.

Drugs covered by this patent

Patent Metadata

Patent number
CA2836449C
Jurisdiction
CA
Classification
—
Expires
2021-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Principia Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.